Last Updated : Oct 02, 2020 07:22 AM IST | Source: Moneycontrol.com

DAILY VOICE: Investors are worried about second wave of COVID-19, says Canara Robeco's Nimesh Chandan

Pharmaceuticals, consumer staples, telecom, and utilities have been less impacted by the COVID-19 pandemic.


Currently, equity investors around the world are worried about the second wave of COVID-19. Valuations have moved up significantly from what they were six months ago and are factoring a better growth trajectory from next year, Nimesh Chandan, Head of Equities, Canara Robeco Mutual Fund, said in an interview with Moneycontrol’s Kshitij Anand.

edited excerpts:

Q) Bulls lost their grip on D-Street in September. Which are the factors that weighed on equity markets?

A) Corrections are a part of the bull market and it is difficult to time them. The equity market has rallied sharply post March 2020 as investors moved from panic to optimism.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

related news

In any rally, there is a point when expectations from the economy and businesses rise so much that stock prices become vulnerable to disappointments.

Investors wait to reaffirm the narrative driving the rally and that can lead to a time or a price correction.

Currently, equity investors around the world are worried about the second wave of COVID-19. Valuations have moved up significantly from what they were six months ago and are factoring a better growth trajectory from next year.

If the incoming data points challenge these assumptions, that could trigger a correction.

Q) Are there any sectors where you are cutting your exposure after the recent rally?

A) At Canara Robeco, we look to invest in companies that have a robust growth-oriented business, are run by competent management and are available at a reasonable valuation.

As a long-term investor, we resist the temptation to react to short-term market moves. However, we do review our exposures in companies where the prices have crossed our bull case scenario or the business developments are not as per our initial expectations.

In the recent past, there is no significant change in terms of our sector allocation except telecom. Within the sector, there could be changes on a stock-specific basis.

Q) We have seen a flurry of IPOs in September. Which are the factors that one should consider while putting their money in an IPO?

A) A company coming for an IPO should be evaluated the same way, as a prudent investor would evaluate an investment in the listed companies.

The focus should be to determine whether the company is a good business to own for a longer-term. The business and valuations of the company coming for an IPO should be evaluated with its listed peers and then one should reach a decision whether to subscribe or not.

For an investor, investing in a company that is already listed for some time has one important advantage compared to investing in a new listing- a good amount of historical data is available about the business performance, management performance, and the valuation range.

Q) Any big themes which can make a portfolio COVID-proof or insulated from external shocks?

A) There are sectors that have been less impacted or even immune to the COVID-19 pandemic. Pharmaceuticals, consumer staples, telecom, and utilities have been less impacted.

In terms of themes- Rural India, Atmanirbhar Bharat, and inflation have been themes that have helped protect the downside as well as participate in the portfolio. However, valuations have moved up significantly for many companies in these sectors and themes.

These sectors and themes can protect the downside if the pandemic situation worsens but one must be selective if one wants to invest for an upward rerating.

Q) COVID might go or fade out after a vaccine but scars on the economy will take time to heal. What are your views?

A) The investors have built-in expectations of normalisation of economic and business activity after the vaccine. If there is a delay in recovery in consumer and business spending, the economic growth and earnings recovery will have to be adjusted downwards.

The second problem markets can encounter is that at some point in time, governments will have to address the high fiscal deficit and high debt to GDP level in the economy.

The fiscal and monetary stimuli given by governments across the world may be withdrawn at some point.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
First Published on Oct 2, 2020 07:22 am